Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lovestone

Showing results (81-90 of 139) with videos related to

Pageof 14
Sort By:
Psychological Medicine|August 13, 2009
Brain anatomy and ageing in non-demented adults with Down's syndrome: an in vivo MRI studyF Beacher, E Daly, A Simmons, et al.
Neuroscience Letters|November 8, 2001
The microtubule associated protein Tau gene and Alzheimer's disease--an association study and meta-analysisC Russ, J F Powell, J Zhao, et al.
FEBS Letters|March 30, 2001
Effects of FTDP-17 mutations on the in vitro phosphorylation of tau by glycogen synthase kinase 3beta identified by mass spectrometry demonstrate certain mutations exert long-range conformational changesJ W Connell, G M Gibb, J C Betts, et al.
Neuroreport|September 2, 1996
Association between a PS-1 intronic polymorphism and late onset Alzheimer's diseaseP Kehoe, J Williams, P Holmans, et al.
FEBS Letters|November 30, 2000
Differential effects of apolipoprotein E isoforms on phosphorylation at specific sites on tau by glycogen synthase kinase-3 beta identified by nano-electrospray mass spectrometryG M Gibb, J Pearce, J C Betts, et al.
Neuroreport|February 10, 1997
Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimer's diseaseT Li, C Holmes, P C Sham, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 16, 2009
Insight, cognition and quality of life in Alzheimer's diseaseC S Hurt, S Banerjee, C Tunnard, et al.
Biochemical Society Symposium|July 13, 2001
Neurofibrillary tangles and tau phosphorylationJ P Brion, B H Anderton, M Authelet, et al.
The Journal of Prevention of Alzheimer'S Disease|May 8, 2019
Plasma Biomarkers of AD Emerging as Essential Tools for Drug Development: An EU/US CTAD Task Force ReportR J Bateman, K Blennow, R Doody, et al.
Genome|November 11, 1998
Isolation and chromosomal mapping of human glycogen synthase kinase-3 alpha and -3 beta encoding genesP C Shaw, A F Davies, K F Lau, et al.
Pageof 14

Showing results (81-90 of 139) with videos related to

Sort By:
Pageof 14
Psychological Medicine|August 13, 2009
Brain anatomy and ageing in non-demented adults with Down's syndrome: an in vivo MRI studyF Beacher, E Daly, A Simmons, et al.
Neuroscience Letters|November 8, 2001
The microtubule associated protein Tau gene and Alzheimer's disease--an association study and meta-analysisC Russ, J F Powell, J Zhao, et al.
FEBS Letters|March 30, 2001
Effects of FTDP-17 mutations on the in vitro phosphorylation of tau by glycogen synthase kinase 3beta identified by mass spectrometry demonstrate certain mutations exert long-range conformational changesJ W Connell, G M Gibb, J C Betts, et al.
Neuroreport|September 2, 1996
Association between a PS-1 intronic polymorphism and late onset Alzheimer's diseaseP Kehoe, J Williams, P Holmans, et al.
FEBS Letters|November 30, 2000
Differential effects of apolipoprotein E isoforms on phosphorylation at specific sites on tau by glycogen synthase kinase-3 beta identified by nano-electrospray mass spectrometryG M Gibb, J Pearce, J C Betts, et al.
Neuroreport|February 10, 1997
Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimer's diseaseT Li, C Holmes, P C Sham, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 16, 2009
Insight, cognition and quality of life in Alzheimer's diseaseC S Hurt, S Banerjee, C Tunnard, et al.
Biochemical Society Symposium|July 13, 2001
Neurofibrillary tangles and tau phosphorylationJ P Brion, B H Anderton, M Authelet, et al.
The Journal of Prevention of Alzheimer'S Disease|May 8, 2019
Plasma Biomarkers of AD Emerging as Essential Tools for Drug Development: An EU/US CTAD Task Force ReportR J Bateman, K Blennow, R Doody, et al.
Genome|November 11, 1998
Isolation and chromosomal mapping of human glycogen synthase kinase-3 alpha and -3 beta encoding genesP C Shaw, A F Davies, K F Lau, et al.
Pageof 14